All news

The company broadens its Pressure Area Care portfolio with acquisition of Genie Care and innovative ToTo product.

Frontier Medical Group ("Frontier"), the specialist medical device manufacturer, today announces its acquisition of Genie Care in a deal that sees Frontier broaden its portfolio and continue its investment in products used in the prevention and treatment of pressure ulcers.

ToTo is a patented product that is recognised as a revolution in helping clinicians and carers in the regular turning of patients. The unique turning platform is placed under any existing mattress and designed to gently turn patients at regular intervals, supporting carers and offering a new approach to “Two Hourly” or “Night Time” turning.

The ToTo system was specifically designed to prevent pressure damage and improve patient comfort, with a proven record of success in recent years. The addition of ToTo is complementary to Frontier’s existing Repose® range of pressure area care products, and will further help clinicians and carers to reduce the prevelance of pressure injuries with clinically and cost effective products in both the acute and community settings.

According to the NHS Stop The Pressure research, 700,000 people in the UK are affected by pressure ulcers each year and between 80% to 95% of these cases are preventable using the recommended SSKIN bundle approach. Repose® and ToTo tackle two of the five SSKIN steps, as Repose® pressure area care products are therapeutic surfaces with over 19 years of clinical evidence and Toto has been proven to help with the regular turning of patients.

Simon Jackson, Managing Director at Frontier Medical Group said: “This exciting acquisition allows us to broaden our range of innovative solutions supporting clinicians around the world, helping them in their work to reduce the prevalence of pressure ulcers. Pressure injury is a major issue in the global healthcare profession, and increasing our range of products will further allow Frontier to improve the lives of individuals who are at risk in both the acute and community settings.”

Mike Wilkinson, Managing Director at Genie Care said: “This integration with Frontier Medical Group is the logical next step for Genie Care. Combining Frontier’s best-in-class pressure area care products with Genie Care’s ToTo patient turning system will provide patients with the most complete pressure area care range in the market”

For more information on this acquisition visit www.frontier-group.co.uk and for more on the Repose® range of products visit www.reposedirect.com.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Frontier Medical:

Simon Jackson/Matthew Bambery +44 1495 235 800

Media Contact:

Fereshta Amir +44 20 3475 7168

frontier@battenhall.net

Kester Capital is delighted to announce that three of its portfolio company management teams were recognised for their achievements at the regional BVCA Management Team Awards 2016 awards.

Frontier Medical Group, a leading provider of medical products, based in Wales, won the award for Wales Mid Market Team of the Year;

Briefing Media, the leading agriculture business information provider, based in London, won the award for South East CEO of the Year; and

Garrets, the global leader in outsourced marine catering management, based in Essex, was a runner up in the Midlands Mid Market Team of the Year;

Kester Capital is pleased to announce an investment in Factory-CRO, a leading CRO focused on the medical device market.

Factory-CRO was founded over 20 years ago by Dr. Dirk Meijer and Dr. Joris Bannenberg. Since then, Factory-CRO has grown to become a leading CRO in the medical device sector. Headquartered in Bilthoven, Netherlands, Factory-CRO conducts trials for its international customer base across the globe. Kester Capital will become a significant shareholder in Factory-CRO and support the business’ growth, both organically and by acquisition, as it looks to build on its unique expertise and impressive track record.

Commenting on the transaction, Dirk Meijer said, “We are very pleased to have secured an investment in our business from Kester Capital. The team at Kester Capital have a detailed understanding of our business and market through their past investment in the sector and we are looking forward to their support as we take the business forward. We are confident that our existing and future customers will benefit from the additional investments we will be making in our business. This includes our US office, which we recently opened, and a number of exciting acquisition opportunities which will extend our reach and expertise in Europe, the USA and Asia-Pacific.”

Adam Maidment, founding partner at Kester Capital said, “Dirk and Joris have built an exceptional business in Factory-CRO and we are delighted to have the opportunity to partner with them to deliver the next phase of the business’ growth. The market for medical device trial expertise is highly specialised and continues to evolve as the regulatory environment develops. Factory-CRO is a leading authority in the medical device arena and has a strong track record of delivering results for its customers.”

ING provided debt facilities in support of the transaction.

Kester Capital was advised by BDO (M&A and FDD), AVOS Consulting (CDD), Travers Smith and NautaDutilh.

For further enquiries please contact

Kester Capital:

Adam Maidment +44 203 747 5700

Factory-CRO:

Dirk Meijer / Joris Bannenberg +31 30 229 2727

Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.

Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.

Now in their eighth year, the 2016 event saw nominees and their guests gather for a gala dinner in Bath Assembly Rooms on the 12th May, and Frontier Medical Group was recognised for the first time following the buyout backed by Kester Capital in December 2013.

The company, which was established in 1966, manufactures a range of cost and clinically effective products for use in community and hospital care, and has enjoyed strong growth in the last few years under its new ownership.

Simon Jackson, Managing Director at Frontier Medical Group said: “This award is a real honour and it’s a testament to the hard work of each and every one of our employees and the quality of the products we provide. In the time since the deal we’ve been able to make a significant investment right across our infrastructure, not only in terms of manufacturing and growing our Export markets, but in our staff as well, and that’s something we as a company are very proud of. We believe it is a significant factor in our ongoing success.”

Commenting on Frontier Medical Group’s entry Richard Young, Director at BVCA said: “Simon Jackson has led a new team at Frontier since the acquisition in 2013, which has transformed the business in terms of sales and marketing strategy, new product development, production efficiency and development of new export markets. The transformation has been hugely impressive.”

Frontier have worked extensively with clinicians in the NHS to develop the Repose® range of pressure area care products, which today are the most widely used pressure area care products in the UK. Over 3.5 million people have used Repose® products in the UK alone.

The firm’s range of disposal units for clinical sharps, Sharpsafe ®, are the world’s first bespoke sharps containers and they have received numerous design awards since they were first marketed in 1980. They are also the UK’s market leader in providing products to Harm Reduction services through its eXchange™ brands.

For more information visit www.frontier-group.co.uk or follow @FMG_Group on Twitter.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Frontier Medical:

Simon Jackson/Matthew Bambery +44 1495 235 800

Media Contact:

Andrew McClenaghan +44 20 7887 2648

andrew.mcclenaghan@battenhall.net

Kester Capital is pleased to announce the refinancing of Frontier Medical on the back of a continued period of profit growth. RBS provided a new term loan the proceeds of which were used to repay investors.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Frontier Medical:

Simon Jackson/Matthew Bambery +44 1495 235 800

This week, the medical device company Frontier Medical Group (Frontier) opens its new Head Office in Blackwood in South Wales. The newly refurbished office will be inaugurated on Frontier’s 50th anniversary, celebrating the milestone with an event on Thursday in the presence of Economy Minister Edwina Hart and Professor Keith Harding CBE (Dean for Clinical Innovation Cardiff University and Medical Director Welsh Wound Innovation Centre), both of whom have witnessed Frontier evolve into a leading local employer and an innovator in the medical devices industry.

This milestone is a testament to Frontier’s commitment to continued innovation and to the sustainability of the company. As well as the new headquarters the company has gone through a rebranding, launched a number of new products in 2015 and is launching its next major new product, Repose® Ultracore, in April this year.

Simon Jackson, Managing Director at Frontier Medical Group said: “Opening our new Head Office in our 50th anniversary year is a major milestone for us. We’re proud to celebrate five decades of pioneering simplicity by providing both cost and clinically effective medical devices that help prevent harm such as needle stick injuries and pressure ulcers.”

“Frontier is a leading supplier of products and services to healthcare providers in the UK, Europe and internationally. Around 25 per cent of our sales come from export markets. The new Head Office is only the beginning of a number of exciting plans we have this year as we continue to invest in our business and expand both our global business and portfolio of products.”

Economy Minister Edwina Hart said: “Frontier is a highly innovative company and its products have made a significant contribution to the health and well being of patients around the world. As a market leader in its field, it is a valued member of the life science sector in Wales and an important local employer. I am delighted to hear of their plans to expand, further invest in the business and launch a range of new products. Today is indeed an important milestone for the company and I wish Frontier every success in the future.”

Frontier recognised the need for a purpose-designed container for the safe disposal of clinical sharps and developed Sharpsafe® - the world’s first bespoke sharps container. Sharpsafe® containers were first marketed in 1980 and received numerous design awards, setting the standard for the regulation that followed. Working with clinicians in the NHS in the 1990s Frontier developed the Repose® range of pressure area care products that are now the most widely used pressure area care products in the UK. Over 3.5 million people have used Repose® products in the UK alone.

Professor Keith Harding CBE Dean for Clinical Innovation Cardiff University and Medical Director at Welsh Wound Innovation Centre said “We have a relationship with Frontier that goes back nearly 20 years as we worked together on developing and proving the clinical efficacy of the Repose® products. All the team at the Welsh Wound Innovation Centre look forward to this relationship continuing as we work together to develop clinically effective products to reduce the prevalence of pressure ulcers.”

Frontier is also the UK’s market leader in providing products to Harm Reduction services through its eXchange™ brands.

Frontier’s new office will officially open on the 25th of February and the newly branded website can be seen here at www.frontier-group.co.uk.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Frontier Medical:

Simon Jackson/Matthew Bambery +44 1495 235 800

Kester Capital is pleased to announce the sale of Garrets International, a market leader in outsourced marine catering services, to Wrist Ship Supply, the world’s leading ship and offshore supplier.

Kester Capital led the primary buy-out of Garrets in early 2012, providing an exit for the founders who also remained minority investors. The sale represents the fifth exit from Kester Capital’s first fund, and generated a 3.1x money multiple and a 38% IRR.

Commenting on the deal, Cameron Crockett, a founding partner of Kester Capital and Garrets non-executive director said, “It has been a pleasure to work with Geoff Battersby and the Garrets team over the last four years. They have significantly strengthened Garrets’ market leading position and successfully professionalised the business during our ownership. We believe that Wrist Ship Supply is a great home for Garrets, and are sure that Garrets' business, staff and customers will prosper under Wrist’s ownership.”

Kester Capital was advised on the transaction by Stephens Europe and Travers Smith.

For further enquiries please contact:

Cameron Crockett

Kester Capital LLP

+44 (0)20 3747 5700

Kester Capital is pleased to announce the sale of Ironshore to Fosun International Limited.

During Kester Capital's investment period, Ironshore built a diversified, global speciality insurance platform with a deep management team. Ironshore's focus on longer-tail liability coverage created a substantial amount of cash float income, which was deployed into the investment portfolio over time. As a result, Ironshore presented an attractive, scalable platform for a strategic acquirer.

Kester Capital originally made its investment in Ironshore in Spring 2007. The exit is the fourth from Kester Capital’s first fund and generated a 2.1x money multiple.

For further enquiries please contact:

Cameron Crockett or Adam Maidment

Kester Capital LLP

+44 (0)20 3747 5700

Kester Capital is pleased to announce the sale of Briefing Media to its management team, backed by Lyceum Capital.

Kester Capital originally acquired the Briefing Media assets from UBM plc in early 2012 and supported the follow on acquisitions of LAMMA in 2012 and AgriMoney in 2014. The exit is the third from Kester Capital’s first fund and generated a 3.5x money multiple and a 57% IRR.

Commenting on the deal, Cameron Crockett, a founding partner of Kester Capital said, “We would like to thank the management team, led by Neil Thackray, Rory Brown and Rupert Levy, for their exceptional work over the last three years. It has been a pleasure to partner with such an outstanding team and we wish them, the wider team and Lyceum every success for the future.”

Neil Thackray, CEO of Briefing Media said, “Kester Capital have been great investors and perhaps most importantly terrific partners for Briefing Media. They backed an ambitious plan and supported us all the way. Together we have been able to achieve a great result for shareholders and a very positive future for our business.”

Kester Capital was advised on the transaction by Clarity, the Jordan Edmiston Group (JEGI) and Travers Smith. Grant Thornton and Plural Strategy Group provided due diligence services.

For further enquiries please contact:

Cameron Crockett or Adam Maidment

Kester Capital LLP

+44 (0)20 3747 5700

Kester Capital portfolio company, Ironshore Inc. (“Ironshore”), and Fosun International Limited announced that they have entered into a definitive agreement for Fosun to acquire the remaining interest in Ironshore that Fosun does not already own. The acquisition of the remaining interest in Ironshore will be effected by the merger of an indirect wholly-owned subsidiary of Fosun International Limited with and into Ironshore, with Ironshore as the surviving company. After giving effect to the merger, Ironshore will be an indirect wholly- owned subsidiary of Fosun International Limited. The transaction is subject to the receipt of regulatory approvals and other customary closing conditions.

Contact us:

Kester Capital: contactus@kestercapital.com / +44 20 3747 5700

Kester Capital portfolio company, Ironshore Inc. (“Ironshore”), and Fosun International Limited (HKEx stock code: 00656, together with its subsidiaries, “Fosun”) announced today that Fosun has completed its purchase of ordinary shares of Ironshore representing 20 percent of Ironshore’s total outstanding ordinary shares on a fully diluted basis, pursuant to the previously announced definitive agreement. Ironshore will use all of the proceeds from the share issuance to fund repurchases of outstanding equity from existing equity holders, including existing long-term, private equity shareholders. After giving effect to Fosun’s equity purchase and Ironshore’s repurchase of outstanding equity from existing equity holders, Fosun will become the largest shareholder of Ironshore.

Contact us:

Kester Capital: contactus@kestercapital.com / +44 20 3747 5700

Following a sustained period of profit growth and cash generation, Kester Capital is pleased to announce the second refinancing of Briefing Media. Barclays provided a new term loan the proceeds of which were used to repay shareholders. Following this second shareholder payment, Kester Capital has realised 1.3x cost on its original investment in Briefing Media.

Contact us:

Kester Capital: Cameron Crockett on +44 20 3747 5700

Garrets is pleased to announce that Per Gullestrup has joined the board as Non-Executive Director. In this capacity, Per will work with the board on strategy and on the development of the wider proposition.

Per started his career with AP Moller Maersk, and has worked within the Clipper Group in various management positions for over 30 years. He now holds a number of non-executive roles, including being Chairman of ISWAN (International Seafarers Welfare Assistance Network) and a Board member of Somali Fair Fishing. (His connection with Somalia dates back to his high profile, successful negotiation for the release of the Clipper Group ship CEC Future and its crew, held hostage by Somali pirates in November 2008). Per remains a partner in Clipper Group but has no involvement in the running of the business.

Geoff Battersby, CEO Garrets, said “Per brings to Garrets a depth and breadth of experience and I believe that his perspective on the development of the shipping industry will be invaluable as we shape the business for the future.”

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Garrets:

Geoff Battersby / enquiries@garrets.com

Briefing Media, the UK’s leading agriculture information and events group, has today acquired Agrimoney, the agriculture investment information specialist.

Agrimoney (www.agrimoney.com) was established in 2009 to provide the link between investors and the global food chain. Since its launch it has grown to attract over 70,000 users per month, across more than 170 countries.

Agrimoney is the latest addition to Briefing Media’s expanding agriculture portfolio which includes Farmers Guardian; Arable Farming; Dairy Farmer; LAMMA, the UK’s leading agriculture machinery show; CropTec; Farmers Weather; LammaXchange and The British Farming Awards.

Commenting on the deal, Rory Brown, co-founder of Briefing Media, said: “Agrimoney is a powerful addition to our agriculture brands and will enable us to expand into adjacent markets and geographies. Agrimoney will now become the spearhead of our further extension into the agri-finance markets through an enhanced product suite of data, news, analysis and commercial meeting places – both face-to-face and online.”

Agrimoney’s founder, Mike Verdin, said: “The increasing numbers of mouths to feed, the demand for ever-more sophisticated diets, and the potential for turning food into fuel has turned the growing business of agriculture into big business. Agriculture – to which financial markets owe a debt of history, even down to the derivation of the word capitalism – is back at the forefront of investment thinking. I am delighted to be joining Briefing Media to work on the evolution of the offering and community which Agrimoney has developed. We have exciting plans for the future.”

Details of the transaction were not disclosed.

Contact us:

Kester Capital: Cameron Crockett / +44 20 3747 5700

Briefing Media: Neil Thackray / info@briefingmedia.com

Agrimoney: newsdesk@agrimoney.com / +44 1432 839 131

Kester Capital portfolio company, Ironshore Inc. (“Ironshore”), and Fosun International Limited (HKEx stock code: 00656, together with its subsidiaries, “Fosun”) announced today that they have entered into a definitive agreement for Fosun to purchase ordinary shares of Ironshore that would represent 20% of Ironshore’s total outstanding ordinary shares on a fully diluted basis. Ironshore will use all of the proceeds from the share issuance to fund repurchases of outstanding ordinary shares from existing shareholders, including existing long-term private equity shareholders. After giving effect to Fosun’s equity purchase and Ironshore’s use of proceeds, Fosun will be the largest shareholder of Ironshore. The transaction is subject to the receipt of regulatory approvals and other customary closing conditions.

Contact us:

Kester Capital: contactus@kestercapital.com / +44 20 3747 5700

Frontier Medical, a leading UK supplier of medical devices and services to the healthcare sector, is pleased to announce the appointment of Simon Jackson as Managing Director.

A graduate in Mechanical and Biomedical Engineering, Simon began his career as a sales executive with Johnson & Johnson. From there he progressed to GE Healthcare and then on to a UK and European leadership role with CR Bard. In 2009 Simon joined Systagenix, a UK-headquartered global wound care business backed by One Equity Partners. Simon was responsible for the European sales and marketing business (USD$100m of sales) before joining Frontier Medical as a Director in March 2014.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Frontier Medical:

Simon Jackson / info@frontier-group.co.uk

Garrets International is today celebrating being named winner of a Queen’s Award for Enterprise for International Trade - the UK’s highest accolade for business success – for the second time.

Approximately 160 Queen’s Awards have been announced this year for outstanding business achievement in the fields of International Trade, Innovation and Sustainable Development.

The awards are made annually by HM The Queen and are only given for the highest levels of excellence demonstrated in each category.

On receiving The Queen’s Award, Garrets International’s CEO Geoff Battersby said: “Receiving the Queen’s Award for Enterprise twice in five years is testament to the significant growth that Garrets International has achieved in recent years. I, the Board and staff of Garrets International are proud to receive this accolade, which is a great reward for the collective efforts invested in growing the company.”

Garrets International is the leading outsourced marine catering management company, established in 1991. From offices in Romford and Singapore the company provides victualing and catering management services to a fleet of about 1,000 merchant ships and total crew of over 20,000. As signified by the Queen’s Award for Enterprise, Garrets International is growing in terms of fleet management and, as a result, staff numbers are increasing and today total 40, with the majority recruited from the Greater Romford area.

Contact us:

Kester Capital:

Cameron Crockett +44 20 3747 5700

Garrets:

Geoff Battersby / enquiries@garrets.com

Kester Capital is pleased to announce the sale of its interest in Chiltern in a deal which values the business at £135m. The exit comes as Chiltern announces the consolidation of existing investors, led by Sir Douglas Myers. The transaction has generated a return of over 2x capital and a 25% IRR for Kester Capital funds.

Chiltern is a leading, global contract research organisation ("CRO") with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas. Chiltern serves a diverse customer base and has conducted trials in over 40 countries. The business employs more than 1,600 people.

Commenting on the transaction, Adam Maidment, Partner at Kester Capital, said: “This marks Kester’s third deal in as many months and we’re delighted to have had such a strong end to the year. Chiltern has been a great asset for us; it is a first rate business with an excellent reputation and we wish the management team led by Nick Thornton and Jim Esinhart the very best for the future.”

Nick Thornton, Chiltern’s Executive Chairman said: “Kester Capital has made a valuable contribution to Chiltern’s development over the last 4 years. They have been a constructive and collaborative partner and have played an important role in helping the business create and then realise value. We would like to thank them for their support across the business as we move on to the next phase of our development.”

Chiltern/Kester Capital were advised by Jefferies and Macfarlanes. Chiltern management were also advised by Travers Smith.

For further enquiries please contact:

Adam Maidment

Kester Capital

+44 (0) 203 747 5700

For further enquiries please contact:

Natalie Chong

Marketing Director

Chiltern International Ltd.

171 Bath Road

Slough

Berkshire SL1 4AA

United Kingdom

Tel: +44 (0) 1753 512 000

Fax: +44 (0) 1753 511 116

Email: natalie.chong@chiltern.com

Kester Capital LLP (“Kester Capital”) is pleased to announce its investment in Frontier Medical Products Limited (“Frontier”).

The Frontier management team, led by Nick Davis and Nigel Harris, have reinvested alongside Kester Capital and the transaction has been supported by new loan facilities from The Royal Bank of Scotland plc (“RBS”).

Founded in 1966, Frontier has grown to become a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and continental Europe. Frontier’s portfolio of highly regarded brands includes: Repose, a differentiated range of pressure area care devices; Sharpsafe, premium quality sharps disposal containers; and eXchange, specialist harm reduction products and services. Frontier is based in Blackwood, Wales, and employs over 250 people.

Nick Davis, Managing Director at Frontier, said: “We are pleased to have secured Kester Capital’s support for our continued growth plans. The investment is testament to the strength of the business and we look forward to capitalising on the growing market opportunity and the foundation we have built over the last 40 years. We are also pleased to be continuing our long standing relationship with RBS.”

Cameron Crockett, Partner at Kester Capital said: “Frontier is a good example of the type of business that Kester Capital looks to back. Pressure area care and infection control have emerged as areas of serious concern for healthcare providers across the world and Frontier has an enviable track record of helping its customers deal with these growing issues both in the UK and overseas.”

RBS provided term and ancillary facilities for the transaction. Commenting, Nick Evans, Director at RBS, said: “We are very pleased to have been able to support this transaction and continue our relationship with Frontier, a strong local business that we have worked with since 1973.”

Kester Capital was advised by CIL, Grant Thornton and Travers Smith.

Frontier was advised by EY and Meade King.

RBS was advised by Osborne Clarke.

For further enquiries please contact:

Kester Capital LLP

+44 (0) 203 747 5700

Cameron Crockett

Frontier Medical Products Limited

+44 (0) 1495 235 839

Nick Davis

Nigel Harris

Matt Bambery

Briefing Media announces that it has sold Pulse, the UK's market-leading magazine, website and learning platform for general practitioners, to Cogora. Ltd.

Cogora is a media and marketing services company specialising in healthcare. Pulse will be integrated into Cogora's portfolio, which includes Nursing in Practice, Management in Practice and The Commissioning Review.

Commenting on the sale, Neil Thackray, CEO of Briefing Media said: "We are extremely proud of the work we have done with the Pulse team since acquiring the business from UBM in 2012. Our user-centric approach has re-positioned the business and driven a much deeper engagement with GPs. Pulse is commerically robost, scored very well in the recent joint industry readership research and is positioned well for its next stage of growth. I know that Cogora will continue to grow this fantastic brand, as Pulse becomes part of a larger healthcare media group."

John Pettifor, Cogora Chief Executive, said: "Pulse is the final piece of the puzzle for our primary healthcare portfolio. For many years we have been producing inspirational and incisive content for practice and community nurses, practice managers and, more recently, clinical commissioners. This acquisition means our reach across the UK's primary care community will be far greater than any other company."

The Pulse assets include the monthly Pulse magazine and associated website, pulsetoday.co.uk. Pulse also hosts a series of events, including Pulse Live, and an online education platform, pulse-learning.co.uk.

Contact us:

Kester Capital: Cameron Crockett / +44 20 3747 5700

Briefing Media: Neil Thackray / info@briefingmedia.com

GCP Capital Partners LLP (GCP Europe), the former European private equity arm of Greenhill & Co, has re-branded as Kester Capital LLP. This follows the introduction earlier in 2013 of private equity funds managed by Goldman Sachs Asset Management as GCP Europe’s new cornerstone investor, alongside a number of other new institutional LPs, to replace Greenhill & Co.

Kester Capital will be led by Cameron Crockett and Adam Maidment, both of whom have been with GCP Europe since 2007. Brian Phillips, Chief Investment Officer at GCP, who led the establishment of GCP Europe for Greenhill in 2006, has moved to a senior advisory position.

Kester Capital will continue its core focus on lower mid-market UK transactions, targeting equity investments of £5 to £25 million.

Commenting on the re-brand, Adam Maidment and Cameron Crockett said:

“We are pleased to have completed this transition to Kester Capital with the support of institutions such as Goldman Sachs Asset Management. We are optimistic about the prospects for mid-market private equity in the UK and the opportunity that this presents to Kester Capital and our investors.”

The re-brand to Kester Capital coincides with the sale of Travel Entertainment Group (TEG) to Global Eagle Entertainment Inc. for a consideration of £23m, generating a return of approximately 1.8x for Kester funds.

TEG, through its main subsidiary IFE Services Limited, is a leading provider of in-flight entertainment solutions to the airline industry and works with a worldwide client-base of over 50 airlines and cruise ship operators. The company is headquartered in the UK with regional offices located in Madrid, Singapore, Santiago, Sao Paulo, Nairobi, Kuala Lumpur, Oberhausen, Johannesburg and California.

Acquired in July 2008 in a primary buy-out, Kester Capital initiated the process of professionalisation in the business, appointing a new CEO and CFO. Under this team, the business has achieved strong organic growth, driven by the positive underlying dynamics of the in-flight entertainment industry and supplemented by a bolt-on acquisition in 2012.

Commenting on the transaction, Adam Maidment said:

"TEG has been a good example of what we set out to do: taking lower mid-market businesses and working with them to professionalise and move to the next level. We’re delighted that, in Global Eagle Entertainment, TEG has a supportive new owner who will be able to capitalise on the business’ achievements to date. We would like to thank the CEO, Andy McEwan, and his team for their excellent work over the last few years and we wish them well in this next phase of the business’ development."

Commenting on the transaction, Andy McEwan, TEG’s CEO, said:

"Over the last few years the business has successfully grown its market share and established itself as a leading provider of in-flight entertainment solutions. Kester Capital have supported the management team throughout this period, assisting in delivering both our organic and acquisition growth. We would like to thank the team at Kester Capital for this support and look forward to joining forces with Global Eagle and continuing to develop our range of services to clients.

"We would also like to thank Harris Williams & Co. who, through their international presence, sector knowledge and senior-led approach, advised Kester Capital and TEG on this successful transaction."

Taylor Wessing LLP and DWF LLP advised Kester and management, respectively.

For further enquiries please contact:

Kester Capital LLP

+44 (0) 203 747 5700

Adam Maidment

Cameron Crockett

Brunswick Group LLP

+44 (0) 207 404 5959

James Olley

Kester Capital is pleased to announce the refinancing of Briefing Media. Barclays provided a new term loan the proceeds of which were used to repay a portion of the initial investment.

Contact us:

Kester Capital: Cameron Crockett / +44 20 3747 5700

Briefing Media: Neil Thackray / info@briefingmedia.com

Briefing Media is delighted to announce the appointment of David Gilbertson as Chairman. As Chairman, David will work with the board on strategy development and acquisitions and be a sounding board and sage counsel.

David is one of the most experienced business media executives in the world. His most recent executive role was as CEO of EMAP (before it was renamed as Top Right Group). Prior to that he was CEO of Informa where he was one of two founders of the business which through organic growth and acquisition became one of the largest and most successful business media groups in the world. Prior to this David was CEO of LLP, the publishers of Lloyd's List. He began his career as a journalist with Metal Bulletin and also had a short spell as MD of The Lancet.

For further enquiries on Kester Capital please contact:

Cameron Crockett

Email: contactus@kestercapital.com

Telephone: +44 20 3747 5700

For further enquiries on Briefing Media please contact:

Neil Thackray

Email: info@briefingmedia.com

Garrets is pleased to announce that Frank Neale has joined the board as Chairman. In this capacity, Frank will work with the board on strategy and on the development of the wider management team.

Frank is a seasoned private equity investor having spent 25 years in the industry. Frank is also an experienced business coach focused on coaching management teams of private equity backed businesses.

Chiltern today announces that after 6 years in the post Glenn Kerkhof will step down as Chief Executive Officer with effect from October 31. Glenn will join Chiltern’s owner Czura Thornton as a Partner and will join Chiltern’s Board of Directors. Glenn will relocate to his native Australia and will lead Czura Thornton’s growth in the Asia Pacific region.

Chiltern also announces the appointment of Jim Esinhart, PhD, as Chiltern’s new CEO with effect from November 1. Jim is currently Chiltern’s Senior Executive Vice President, Global Scientific Services and has served with the Company for 6 years. Jim has more than 24 years of industry experience and brings an outstanding track record of scientific excellence, operating performance and service delivery.

Mr. Kerkhof said: “I am delighted to have played my part in the development of Chiltern as a leading mid-tier CRO. Chiltern now employs more than 1,400 people in 34 countries, is financially very strong and is poised for substantial growth. I am also delighted to see the CEO position transition to a valued and trusted colleague in Jim Esinhart, who I know will bring a tremendous amount to the role. And I very much look forward to contributing to Chiltern’s future as a member of the Board based in the Asia Pacific region.”

Dr Esinhart added: “On behalf of the whole Chiltern team I would like to pay tribute to Glenn, who has been a fantastic leader of our Company. I am thrilled to have the opportunity to succeed him as Chiltern’s CEO and to continue our mission to deliver expert, high quality and comprehensive clinical development services to our clients around the world. I am excited by the momentum we have at Chiltern, by the strength of our team, the depth of our client partnerships and by the development opportunities we see.”

Briefing Media – a leading provider business-to-business media within the agriculture and healthcare verticals - has announced the acquisition of LAMMA, the UK’s leading farm machinery, equipment and services show.

Lloyds Bank Wholesale Banking & Markets has financed a £41.7 million debt package to support the recapitalisation of Chiltern International, the GCP Capital and Czura Thornton backed global contract research organisation.

Based in Slough and founded in 1982, Chiltern provides a broad range of services relating to the outsourcing of clinical trials including end-to-end trial management, data collection and analysis, and industry resourcing to a global customer base in the pharmaceutical, biotech and medical device industries.

The business, which employs over 1,400 people and operates from offices in 24 countries, has extensive experience in the management of Phase II to IV clinical trials in a broad range of therapeutic areas and contract staffing solutions and has established preferred partner relationships with some of the world’s leading pharmaceutical companies.

With the support of GCP Capital, Czura Thornton and Lloyds Bank, Chiltern’s experienced management team will continue to focus on further enhancing its technical expertise, reliability and high quality customer service proposition globally, as well as identifying complementary, strategic bolt-on acquisitions in high growth territories.

Neale Broadhead, Managing Director at Acquisition Finance, said: “The growing complexity of regulatory approval and looming ‘patent cliff’, which will see companies seek to replace previously patent secured revenue streams by growing research and development spending, will result in pharmaceutical businesses increasingly turning to outsourced services suppliers.

“Chiltern is well positioned to capitalise on these conditions to enable further expansion, with its experienced, acquisitive management team, track record in supporting global clinical trials and stable revenue pipeline.

“The deal has enabled us to continue our long-term support for Chiltern, leading the recapitalisation of the business in recognition of the strong equity value generated in recent years.”

Travel Entertainment Group (TEG) – a leading provider of in-flight entertainment services - has announced the acquisition of The Inflight Entertainment Company (IFECo). IFECo was founded by Arthur Jamieson and provides inflight entertainment services to a number of airlines internationally. Following the acquisition, Arthur will remain as a consultant to TEG for a period.

GCP Capital Partners LLP (“GCP”) announces the acquisition of Garrets International Limited (“Garrets”), the leading international provider of marine catering management for the commercial shipping industry.

Derrick Samms founded Garrets in 1991 and has since pioneered the market for outsourcing of catering services for the merchant navy. Garrets provides its customers with a range of services including provisions supply, stock keeping, quality control and chef training and support.

The business has grown rapidly over recent years and today manages a fleet of 750 vessels from its head office in Romford, making it the clear market leader. The company was recently featured in the Sunday Times International Track 100 as one of the UK’s fastest-growing international companies.

Brian Phillips, Partner at GCP, said: “We are very excited about this primary buyout opportunity. Garrets operates in an attractive market and is well-placed to capitalise on its market leading position to capture further growth. Derrick has done an outstanding job taking Garrets to where it is today and we are delighted to have his continued commitment to the business.”

Having led the market in marine catering for over 20 years, Garrets has developed an enviable reputation for quality and customer service amongst suppliers, competitors and, most importantly, customers, which include some of the largest names in world shipping

Derrick Samms, Managing Director, commented: "We are delighted to announce our partnership with GCP, which will allow Garrets to embark on the next phase of its strategy to grow its position as the leading global outsourced supplier for the marine catering sector."

The vendor was advised by Robert Auerbach, Head of Mergers & Acquisitions at WH Ireland, who specialises in advising entrepreneurs on business sales and capital raisings.

Contact us

Kester Capital: contactus@kestercapital.com / +44 20 3747 5700

Garrets: enquiries@garrets.com

GCP Capital Partners LLP (“GCP Capital”) announces the formation of Briefing Media through the acquisition of two leading business media assets, Farmers Guardian and Pulse, from UBM plc. This transaction provides the opportunity to further develop these brands and pursue conventional and digital media opportunities over the coming years. GCP Capital will also be actively seeking to identify and acquire further assets with similar characteristics.

Farmers Guardian is a weekly newspaper and website covering the farming and agriculture sector, primarily based in Preston. Pulse is a weekly magazine, website and events organiser for general practitioners and primary healthcare professionals in the UK, based in London. Both Farmers Guardian and Pulse are well established with a long history and strong reputation in their respective sectors.

Cameron Crockett, Partner at GCP Capital, said: "The opportunity to back this high calibre management team of Neil Thackray, Rory Brown and Rupert Levy to acquire the Farmers Guardian and Pulse assets was an attractive proposition for us. They have an impressive track record in the media space and we are delighted to be working with them to build on the foundation that this transaction has laid. We are strong advocates of value creation through buy and build strategies and we will be actively looking to support them in the acquisition of further business media assets."

For GCP Capital, this transaction builds on their investment track record in the media sector, having recently acquired World Trade Group, a business-to-business events organiser. GCP Capital has also invested in Travel Entertainment Group, a provider of in-flight entertainment services.

For further information please contact:

GCP Capital Partners

Cameron Crockett

Adam Maidment

+44 207 198 7400

Briefing Media

Neil Thackray

Rory Brown

+44 207 332 2900

GCP Capital Partners LLP (“GCP Capital”) is pleased to announce that it is supporting Peter McDermott and his management team through an investment in ShoppingAtHome Limited. The investment will facilitate the development of their initial gardening offering, You Garden (www.YouGarden.com). GCP Capital intends to support the management team with additional capital for acquisitions in the home shopping sector as it builds a multi-product and multi-channel business to consumer platform.

Cameron Crockett, Partner at GCP Capital, said: "We have evaluated numerous home shopping opportunities and teams and have been very impressed by Peter’s approach and outstanding track record and the Shopping @ Home business model. We are actively looking to grow the business through acquisition."

Peter McDermott, Founder and CEO, commented: “GCP Capital have demonstrated a thorough understanding of the home shopping sector and in particular the gardening market. They have a strong appetite for both organic and acquisitive growth. I look forward to working with them to create a business of scale, serving a diverse section of the home shopping market in the UK, within and beyond the garden market.”

For further information please contact:

GCP Capital Partners

Cameron Crockett

Ian Wood

+44 207 198 7400

ShoppingAtHome / You Garden

Peter McDermott

+44 207 332 2900

GCP Capital Partners LLP (“GCP”) announces the acquisition of World Trade Group (“WTG”), a leading international provider of business-to-business events, training and online lead generation services, in a £27.5m management buy-out.

WTG was founded in 1997 by Victor Lewis and the current CEO, Andrew Brown, and runs a broad portfolio of large-scale business summits in Europe, North America and Asia. The company also has a fast-growing portfolio of online products and technical training courses. WTG is focused on global growth sectors such as energy and pharmaceuticals and was recently featured in the Sunday Times International Track 100 as one of the UK’s fastest-growing international companies.

Adam Maidment, Partner of GCP, said: “GCP favours supporting primary buy-outs of businesses with a strong track record and good growth prospects in attractive markets. WTG fits all of these criteria. WTG’s summits, which provide businesses with a valuable source of lead generation, are clearly differentiated from other business events and occupy an attractive niche in the growing face-to-face business events market. The business is well-positioned to continue to build on its excellent track record and capture further growth in new territories and with new products.”

GCP has taken a majority stake in the business and is supporting Andrew Brown and his management team with their strategy of continued geographic and sector expansion in business summits and extension of their successful online offering. In addition, GCP has made further funding available to expand WTG’s geographic and sector reach through selected, complementary acquisitions.

Andrew Brown, WTG’s CEO, said: “We were looking for a partner who had the right level of ambition and strategic drive, a partner that could really add value. I am confident we have found the perfect match with GCP who support our growth plans and our vision for transitioning WTG into a major global media and events business in the next 3-4 years.”

The acquisition is GCP’s second in the media services sector, following its investment in Travel Entertainment Group, one of the world’s leading providers of in-flight entertainment services to the airline industry.

Mr. Maidment continued, “Media services is a sector with a number of attractive underlying characteristics. We look forward to exploring further investment opportunities in the sector.”

For further enquiries please contact:

Adam Maidment

+44 (0) 203 747 5700

London, England, 25 January 2010 — Greenhill Capital Partners Europe LLP (“GCPE”) is pleased to announce the completion of an investment in Chiltern International Group Limited (“Chiltern”), a leading global contract research organisation. GCPE has acquired its stake in Chiltern for an undisclosed price from one of the investors who backed the management buy-in (MBI) of Chiltern in 2006. GCPE intends to make further capital available to the company to facilitate growth by acquisition.

Chiltern was acquired in 2006 by a team headed by the Executive Chairman, Nick Thornton, and CEO, Glenn Kerkhof. Since then, Chiltern has grown rapidly through both organic and acquisitive growth, expanding its global footprint and service offering. Chiltern provides clinical trial management and related services to a wide range of customers in the pharmaceutical and biotechnology space.

Adam Maidment, Principal of GCPE, who will join the Board of Chiltern, said:

“Nick, Glenn and the management team at Chiltern have developed an exceptional business over the last three years and we are delighted to have the opportunity to support them in the continued growth and success of the business.”

For further information please contact:

GCPE

Adam Maidment

020-7198-7400

Chiltern

Nick Thornton

01753-216-622

Brunswick Group

Eilis Murphy

020-7404-5959

Value of Principal Investments Portfolio to be Realized Over Time and Primarily Returned to Shareholders Via Share Repurchases and Dividends

NEW YORK, Oct. 28, 2009-- Greenhill & Co., Inc. ("Greenhill") (NYSE: GHL) today announced a plan to focus entirely on its client advisory business following an agreement to sell the right to launch successor funds to its three merchant banking funds and thereby transition out of merchant banking activities over time. The key elements of the sale agreement and related plans are as follows:

• The sale price will be $25 million, payable principally in Greenhill common stock, which will be retired. The purchaser will be an entity formed by Robert H. Niehaus, Chairman of Greenhill Capital Partners. Completion of the transaction is expected to occur in the current quarter.
• Existing funds will continue to be managed by Greenhill through Mr. Niehaus and other current personnel, all of whom are expected to remain Greenhill employees until transitioned at a later date to the purchasing entity. Following the transition of Mr. Niehaus and other employees to the new entity, Mr. Niehaus will remain a Senior Advisor to the Firm.
• Greenhill will retain its portfolio of Principal Investments, which had a fair market value of $178.5 million as of September 30, 2009, and will work along with the relevant fund investment teams to maximize the value thereof over a number of years. The Firm intends to use the proceeds of the portfolio, as and when realized, to fund share repurchases and dividends as well as to reduce its modest outstanding debt. Greenhill will make a modest commitment (which will not be charged fees or a profit override) to two successor funds planned by the purchasing entity, and it will own a modest portion of the profit override (or carried interest) in existing funds as well as the two successor funds.
• Greenhill's fund placement advisory group will remain as part of Greenhill’s ongoing advisory business and will act as placement agent for the purchasing entity in raising the two planned funds, on customary fee arrangements. Greenhill may also perform other client advisory services for the new entity and its fund portfolio companies from time to time.

"Since inception, Greenhill’s main business has always been providing advice to large corporate and institutional clients on important matters, and we have always been much more narrowly focused on that business than any of our significant competitors. Today's announcement indicates our intention to focus entirely on that business going forward. There are several factors that led us to this decision. First, even at low points in the cycle like we have been recently experiencing, the market for advisory services is a large one, in which we have a very small market share despite all our success to date. The scale of the opportunity merits our undivided attention. Second, many market observers believe that we are at the beginning of an upturn in the level of transaction activity. In past cycles, transaction activity has expanded dramatically from trough levels. Third, by nearly doubling the number of Managing Directors in our advisory business since early last year, as well as doubling our offices and substantially increasing our industry sector coverage, we have substantially grown our advisory capacity. Our market share has grown significantly over our nearly 14 year history, demonstrated most recently by our year to date advisory revenue performance compared to that of our large competitors, but it remains modest. We believe there remains significant potential for further market share growth as our recent recruits get up to speed and as we add further new geographic and industry sector coverage," said Robert F. Greenhill, Chairman of Greenhill.

"This transaction is good for our clients and our shareholders. From a client perspective, we will have the least potential for conflicts compared to our much more diversified competitors, and we have no product to sell other than independent advice based on our experience and expertise. All our resources, from senior management on down, will be focused on advising clients. From a shareholder perspective, the transaction is immediately accretive. More importantly, it leaves us in a single business – one that historically has had significant growth, very high profit margins and very modest capital requirements. By avoiding significant additional cash commitments to new funds, we can maximize the value of our large existing portfolio over time, return that value to shareholders through share repurchases and dividends, and continue to expand our client advisory business. At the same time, the transaction begins a transition away from what has been a source of extraordinary revenue and earnings volatility, although earnings volatility inherent in the advisory business will obviously remain," added Scott L. Bok, Co-Chief Executive Officer.

"It should not be forgotten that our merchant banking business produced substantial revenue and profits in our early years as a public company, which provided the funding to grow the advisory business substantially while keeping our profit margins and returns on equity at levels significantly higher than those of our peers. Our transition to an exit from merchant banking is not a reflection of the quality or the potential of that business. It is merely a reflection of the fact that the opportunity we see in the client advisory business has expanded considerably, and that capital needs and other differences between the two businesses inevitably become more pronounced as they each grow. We now believe it is easier for each business to continue to grow and prosper under separate, independent ownership," said Simon A. Borrows, Co-Chief Executive Officer.

"My Greenhill Capital Partners colleagues and I are pleased to transition into this next stage of our investment business. We have built a successful investment portfolio, strategy and team of 20 investment professionals over the past ten years. We are proud of the investment record that we have achieved over this time period and are appreciative of the support and the capital that Greenhill and its professionals have provided to us. We look forward to a strong continuing relationship with the Firm and its team of talented advisory professionals. While we will become an independent entity, our strategy, industry focus, portfolio, current funds and access to the Greenhill team and its relationships will remain in place," said Robert H. Niehaus, Chairman of Greenhill Capital Partners.

Contact

Richard J. Lieb

Chief Financial Officer

Greenhill & Co., Inc.

(212) 389-1800

NEW YORK, December 22, 2009 – Greenhill & Co., Inc. (“Greenhill”) (NYSE: GHL) today announced that it had closed the sale of certain assets related to its merchant banking business in connection with its previously announced plan to focus entirely on its client advisory business over time, to Robert H. Niehaus, the Chairman of Greenhill Capital Partners, and V. Frank Pottow, a member of the investment committee of Greenhill Capital Partners, in exchange for 289,050 shares of Greenhill common stock. As previously announced, Greenhill will retain its existing portfolio of principal investments, with the intention of realizing the value thereof over time.

Greenhill Capital Partners Europe LLP (“GCPE”) and the shareholders of the Travel Entertainment Group Ltd (“TEG”) are pleased to announce the completion of an investment in TEG by GCPE. As a consequence of this investment, GCPE will become a significant minority shareholder in TEG, with the existing shareholders and management remaining as majority shareholders.

TEG was founded in 1997 by Mark Hogg, the current chief executive of the business, and is one of the world’s leading providers of in-flight entertainment to the airline industry, as well as satellite and pre-recorded entertainment to the passenger cruise industry. TEG is headquartered in the UK and supports its global client base through a worldwide office network. Mark Hogg will remain as CEO following the transaction.

Mark Hogg, chief executive of TEG, said:

“I am very pleased to welcome GCPE as an investor in the business. GPCE is an ideal partner and will allow us to accelerate and build on our recent rapid growth and success.”

Adam Maidment, Principal of GCPE, said:

“Mark and his team have built a very successful business over the past decade and we are delighted to have the opportunity to support them in the continued growth and development of the business.”

For further information please contact:

GCPE

Adam Maidment

+44 (0) 203 747 5700

NEW YORK, December 17–Greenhill & Co., Inc. (NYSE: GHL) announced today that it has completed the final closing of its first European mid-market buyout fund, Greenhill Capital Partners Europe, L.P. and related funds (the “Fund” or “GCP Europe”). Total committed capital as of the final closing is £191 million.

Of the total funds committed, Greenhill & Co. has committed £25 million. In addition, Greenhill’s managing directors and other professionals have personally committed a further £42 million. The remaining 65% of committed capital has been raised from a variety of institutional investors, high net worth families and qualified corporate executives. Committed capital is expected to be drawn down from time to time over an investment period of up to five years to fund investments by the Fund.

GCP Europe makes private equity and equity-related investments in mid-market companies located primarily in the United Kingdom and Continental Europe. It generally makes controlling or influential minority investments of £10 million to £30 million in companies with enterprise values of £50 million to £250 million.

Since the Fund’s first closing on May 10, 2007, GCP Europe has completed an investment in Ironshore Inc. and the acquisition of Rileys Ltd. Ironshore is a recently formed primary insurance company based in Bermuda. Rileys Ltd. is the UK’s leading cue sports operator, with over 150 clubs and a total membership of over 500,000 people.

Simon Borrows, Co-Chief Executive Officer of Greenhill & Co., said, “We are delighted with the fund raising for our first European private equity fund. Since 2000, we have built a successful merchant banking business in the United States with Greenhill Capital Partners I and II, and Greenhill SAVP. The establishment of GCP Europe is another exciting step and takes our merchant banking capabilities into new markets.”

Brian Phillips, Chief Investment Officer of GCP Europe, said, “We are pleased to have completed our fund raising and, having already made two investments, look forward to turning our full attention to investing the fund in what we believe are increasingly attractive conditions for mid-market buyout funds.”

Greenhill & Co., Inc. is a leading independent investment bank that provides financial advice on significant mergers, acquisitions and restructurings and manages merchant banking funds. It acts for clients located throughout the world from its offices in New York, London, Frankfurt, Toronto and Dallas.

LONDON, July 27, 2007 — Greenhill Capital Partners Europe LLP, (“GCPE”), the European private equity arm of Greenhill & Co., Inc (“Greenhill”), and JOHCM Private Equity, the private equity division of JO Hambro Capital Management, (“JOHCM PE”) today announce that they have entered into an agreement to acquire Rileys Limited (“Rileys”), the UK’s leading cue sports operator, from Georgica PLC (“Georgica”) for a consideration of £30.5 million. GCPE and JOHCM PE jointly led the acquisition and will share equally in the funding of it.

Completion of the acquisition is expected to take place by 31st August 2007.

Rileys is the largest operator of cue sports clubs in Great Britain, with over 150 sites across the nation offering cue sports, licensed bar, food facilities, and gaming machines, with a total membership of over half a million people. The clubs are private members’ clubs and the cue sports offered include both snooker and pool (English and American). In addition, informal social poker evenings are offered by the majority of Rileys’ clubs. For the 12 months ended 31 December 2006, Rileys recorded revenues of £58.2 million and EBITDA of £9.5 million.

Brian Phillips, Chief Investment Officer of GCPE, Charles Barlow, a Managing Director of GCPE and Jeremy Brade and Christopher Mills both of JOHCM PE, will join the Board of Crucible Holdings Ltd (“Crucible”), a new holding company formed to effect the acquisition.

Commenting on the acquisition, Brian Phillips said: “We are delighted to be announcing the acquisition of Rileys and we have exciting plans to expand the number of outlets we operate, through a strategy of both acquisitive and organic growth. We will also continue to refurbish and refresh our existing sites and look forward to working with the management team which will remain with the business.”

Jeremy Brade commented, “The acquisition of Rileys complements our longstanding experience in the leisure sector and we look forward to supporting the growth of the business.”

Further enquiries:

GCPE:

Brian Phillips (Chief Investment Officer)

Charles Barlow (Managing Director)

Tel: +44-(0)20-7198-7400

JOHCM Private Equity:

Jeremy Brade (Senior Fund Manager)

Christopher Mills (Chief Investment Officer)

Tel: +44-(0)20-7747-5602

Tulchan Communications:

Paul Harris

Tel: +44-20-7353-4200

NEW YORK, May 10, 2007 / PRNewswire-FirstCall — Greenhill & Co., Inc. (NYSE: GHL) announced today that it has completed the first closing of its first European mid-market buyout fund, Greenhill Capital Partners Europe, L.P. and related funds (the “Fund” or “GCP Europe”). Total committed capital for the first closing is 106 million pounds Sterling.

Greenhill & Co. has committed 25 million pounds. In addition, Greenhill’s managing directors and other professionals have personally committed a further 39.5 million pounds, for a total of 64.5 million pounds of committed capital coming from the Firm and its employees. The remaining 39% of committed capital has been raised from a variety of institutional investors, wealthy families and qualified corporate executives. Committed capital is expected to be drawn down from time to time over an investment period of up to five years to fund investments by the Fund.

The Fund expects to make private equity and equity-related investments in mid-market companies located primarily in the United Kingdom and Continental Europe. GCP Europe will generally make controlling or influential minority investments of 10 million pounds to 30 million pounds in companies with enterprise values of 50 million pounds to 250 million pounds.

Robert F. Greenhill, Chairman and Chief Executive Officer of Greenhill & Co., said, “the creation of our first European private equity fund is an important step in our strategy of expanding our merchant banking activities. Like our US fund, GCP Europe will focus on much smaller transactions than those on which our client advisory business is focused, thereby avoiding any potential for conflicts.”

Simon Borrows, Co-President of Greenhill & Co., remarked that “the large capital contributions by the Firm and its managing directors demonstrate our commitment to the successful launch of this new activity.”

Brian Phillips, Chief Investment Officer of GCP Europe, said, “the success of Greenhill Capital in the US has made clear that this Firm is an excellent platform for launching a private equity fund targeted at the smaller end of the mid market.” The industry knowledge, transaction expertise and corporate relationships of the Firm’s managing directors will all be very useful.”

Greenhill & Co., Inc., founded in 1996, is a leading independent investment bank that provides financial advisory and merchant banking fund management services. It acts for clients located throughout the world from its offices in New York, London, Frankfurt, Toronto and Dallas. For more information, please visit https://www.greenhill.com/.

(INVESTMENT CLOSED IN 2006)

HAMILTON, BERMUDA, January 3 – Ironshore Inc. announced today that it has raised more than $1 billion through a private placement of its equity securities, and it will begin underwriting specialty lines of insurance immediately through its Bermuda-based insurance subsidiary, Ironshore Insurance Ltd. This newly formed global insurance company was created in response to the crisis conditions in the U.S. property catastrophe insurance markets, a result of unprecedented hurricane activity in recent years and subsequent changes in the insurance industry that make such coverage capital intensive and much more costly.

Initially, Ironshore will write a worldwide book of property business. Because of marketplace demands, the company’s initial focus will be on commercial risks with wind exposures in the catastrophe-prone coastal states such as Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina and Texas, as well as the Caribbean and Yucatan Peninsula. Ironshore will also provide commercial earthquake coverage in California.

Ironshore management and staff will be based in Bermuda, led by Robert V. Deutsch as Chief Executive Officer and Leslie J. Rock as President and Chief Underwriting Officer. Mr. Deutsch is a highly regarded executive who has worked in the insurance industry for 25 years, having served in leading roles with two major insurance companies. Mr. Rock has long been recognized as the leading property underwriter at Lloyd’s, having served as chief property underwriter for three of its leading property syndicates over the past 25 years. Ironshore’s leadership team also includes Mitchell E. Blaser, most recently the CFO of Swiss Re America and Marsh Inc, who has been appointed Chief Financial Officer.

“In the wake of Hurricane Katrina and other notable catastrophic events over the past two years, tens of billions of dollars have flowed into the reinsurance sector, but to date, permanent, adequate capacity has not been established on the insurance side,” stated Deutsch. “Ironshore is very pleased to be able to provide significant new insurance capacity with a substantial, unencumbered capital base and a proven, strong management team.”

The founders of Ironshore are Robert Clements and John Clements through their investment vehicle, Tara Partners Fund LLC, and Ironshore management. The company’s founding investors are Bear Stearns Merchant Banking, Corporate Partners (a business unit of Lazard Alternative Investments), Fremont Partners, TowerBrook Capital Partners and Greenhill Capital Partners. Integro Ltd., a leading global insurance broker that focuses primarily on buyers of insurance with large and/or complex risks, is a sponsor of Ironshore.

Robert Clements is recognized for his industry leadership in creating insurance solutions in response to insurance market dislocations over the past 20 years, having founded a number of Bermuda domiciled insurance and reinsurance companies, including ACE Limited, XL Capital Ltd., Mid Ocean Ltd and, most recently, Arch Capital Group Ltd. Robert Clements said, “Integro initiated the idea of Ironshore as an independent, open-market facility available to all brokers, which we know from experience works best for all concerned.”

Ironshore Founding Investors

BSMB, the private equity affiliate of The Bear Stearns Companies Inc. (NYSE: BSC), invests private equity capital in compelling leveraged buyouts, recapitalizations and growth capital opportunities alongside superior management teams. BSMB focuses on investments principally in middle-market retail, financial services and consumer products companies. Since its formation in 1997, BSMB has been an investor in over 50 portfolio companies. BSMB manages nearly $5 billion of private equity capital, including its new $2.7 billion institutional fund and capital dedicated to its affiliate, Bear Growth Capital Partners. More information about BSMB can be found at www.bsmb.com.

Corporate Partners II is a private equity fund targeting significant minority-stake investments in established public and private companies. Corporate Partners invests in solutions by providing equity and equity-related capital to support companies where there is a value-added use of proceeds such as a strategic acquisition, the pursuit of a growth initiative, strengthening the balance sheet, increasing shareholder stability and other important corporate needs. Corporate Partners is a business unit of Lazard Alternative Investments, a merchant banking firm that manages over $2 billion. For more information on Corporate Partners, go to www.corporatepartnersllc.com.

Fremont Partners, founded in 1991, is a private investment partnership that has managed more than $2 billion of equity investments in 22 companies, representing a total transaction value of $5.6 billion. With offices in San Francisco and Boston, Fremont invests across a diverse range of industries, including financial services, business services, food and consumer products, healthcare, building products, and industrial manufacturing. Fremont Partners makes substantial equity investments in operating companies, typically with enterprise values up to $1 billion, and seeks to build long term sustainable value by working with management teams to implement strategic and operating initiatives. Its website may be found at www.fremontpartners.com.

TowerBrook Capital Partners, L.P. is a private equity firm with more than $2.5 billion under management. The firm has offices in London and New York and focuses on making investments in European and North American companies. TowerBrook pursues private equity investments in large and middle market companies, partnering with highly capable management teams. www.towerbrook.com

Greenhill Capital manages several private equity funds with an aggregate of $1.3 billion in committed capital, focusing on the financial services, energy and telecommunications industries. Its publicly traded portfolio companies include: Global Signal Inc., Heartland Payment Systems, Inc. and Hercules Offshore, Inc. Greenhill Capital is an affiliate of Greenhill & Co., Inc. (NYSE: GHL), an independent global investment banking firm with offices in New York, London, Frankfurt, Toronto and Dallas. For more information about Greenhill Capital, please visit http://www.greenhillcapitalpartners.com.

Tara Investment Partners LLC and its affiliated funds were formed by Robert Clements and John Clements to partner with leading management teams and sophisticated investors in making private equity investment in the insurance industry.

Integro, through its subsidiaries, is an insurance brokerage and risk management firm dedicated to serving clients with large and/or complex risks. Integro has offices in New York, San Francisco, Chicago, Atlanta, Bermuda, Toronto, Montreal, London and Stockholm. Its headquarter office is located at 3 Times Square, 9th Floor, New York, New York, 10036. 1-877-688-8701. More information about Integro is available at www.integrogroup.com.

Ironshore Insurance Ltd. will be located at Swan Building, 3rd Floor, 26 Victoria Street, Hamilton HM 12, Bermuda, 441-279-8200.

The securities have not been registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States unless registered under the Securities Act or under an applicable exemption from such registration requirements. This release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.